News und Analysen

Shares of RXO Inc. (NYSE: RXO) are up more than 20% on the week, something investors probably didn’t see coming out of the ‘boring’ transportation sector. This sector is notorious for having a low

The biotechnology sector, represented by the iShares Biotechnology ETF (NASDAQ: IBB), has experienced a year of consolidation. With the ETF up just 0.8%, it has underperformed the broader market

The biotechnology sector, represented by the iShares Biotechnology ETF (NASDAQ: IBB), has experienced a year of consolidation. With the ETF up just 0.8%, it has underperformed the broader market

The biotechnology sector, represented by the iShares Biotechnology ETF (NASDAQ: IBB), has experienced a year of consolidation. With the ETF up just 0.8%, it has underperformed the broader market

The new commodity cycle is underway, and typically, two items take the lead wherever the cycle is headed. Of course, these two widely watched leaders are oil and gold prices, as both are reliable

As investors prepare for the second half of the year, one question is whether they should take NVIDIA Corp. (NASDAQ: NVDA) or the field. In this case, the field refers to other stocks that make up

As investors prepare for the second half of the year, one question is whether they should take NVIDIA Corp. (NASDAQ: NVDA) or the field. In this case, the field refers to other stocks that make up

As investors prepare for the second half of the year, one question is whether they should take NVIDIA Corp. (NASDAQ: NVDA) or the field. In this case, the field refers to other stocks that make up

As investors prepare for the second half of the year, one question is whether they should take NVIDIA Corp. (NASDAQ: NVDA) or the field. In this case, the field refers to other stocks that make up

While most steel producer stocks are trading down in 2024, Steel Dynamics Inc. (NASDAQ: STLD) is an exception. Its stock is trading up 9.1% year-to-date (YTD). The VanEck Steel ETF (NYSEARCA:

Artificial intelligence (AI) data cloud provider Snowflake Inc. (NYSE: SNOW) has had a series of misfortunate events, ranging from an earnings miss to data breaches, that caused its stock to

High volume can indicate market strength, but volume is relative. Thirty million in traded shares doesn’t mean much if the average daily volume is higher. However, a volume spike to thirty million

High volume can indicate market strength, but volume is relative. Thirty million in traded shares doesn’t mean much if the average daily volume is higher. However, a volume spike to thirty million

High volume can indicate market strength, but volume is relative. Thirty million in traded shares doesn’t mean much if the average daily volume is higher. However, a volume spike to thirty million

Pharmaceutical giant Pfizer Inc. (NYSE: PFE) has been trying to enter the weight-loss treatment trend dominated by GLP-1 drug makers like Ozempic and Wegovy makers Novo Nordisk A/S (NYSE: NVO) a

Pharmaceutical giant Pfizer Inc. (NYSE: PFE) has been trying to enter the weight-loss treatment trend dominated by GLP-1 drug makers like Ozempic and Wegovy makers Novo Nordisk A/S (NYSE: NVO) a

Analysts' sentiment has Workday (NASDAQ: WDAY)  and SolarEdge (NASDAQ: SEDG) down, but the takeaways differ for each. On the one hand, a struggling business continues to lose money while its

Leading cybersecurity provider Fortinet Inc. (NASDAQ: FTNT) stock has been lagging behind its peers and the benchmark indexes, trading up just 3.8% year-to-date (YTD). The company offers

Leading cybersecurity provider Fortinet Inc. (NASDAQ: FTNT) stock has been lagging behind its peers and the benchmark indexes, trading up just 3.8% year-to-date (YTD). The company offers

The homebuilders industry and construction stocks have been in the spotlight recently, and the XHB SPDR S&P Homebuilders ETF (NYSE: XHB) is currently at a pivotal support level. As the ETF hovers

Every once in a while, the Federal Reserve has to step aside from its primary function of keeping markets safe and employment running strong - without too much inflation - to ensure banks are

Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound. Mounjaro is prescribed for Type 2 diabetes but is

When investors consider the main ways to get their money back from an investment and a reasonable return on that initial investment, the average retail investor thinks of two main approaches

When investors consider the main ways to get their money back from an investment and a reasonable return on that initial investment, the average retail investor thinks of two main approaches

When investors consider the main ways to get their money back from an investment and a reasonable return on that initial investment, the average retail investor thinks of two main approaches